Qurexa Logo
Qurexa

Trust. Care. Deliver.

Back to Blog & Insights
Technology

The 'impossible' backup route cells use to survive - and why cancer researchers care

Qurexa Editorial Team25 September 20266 min read 0 0
The 'impossible' backup route cells use to survive - and why cancer researchers care

What happened

Scientists at Montana State University have found that mammalian cells can make an essential building block by a route that was thought to be impossible. The building block is cysteine. It is an amino acid - one of the small parts cells string together to make proteins. Cysteine does two jobs that matter a great deal. It helps build proteins, and it helps form disulfide bonds, which are the chemical clips that hold a protein in the right three-dimensional shape. A protein with the wrong shape does not work. So cells guard their cysteine supply closely. Until now, biologists believed cells had essentially one way to get it. Cysteine mostly arrives in a paired-up form called cystine, and cells use a system of enzymes called disulfide reductases to split the pair apart and free up usable cysteine. Disable that system, the thinking went, and the cell runs out and dies. The Montana State team disabled it anyway. The cells did not die. Instead, the cells switched to something else. Rather than splitting the pair at the expected point, they chemically cut an adjacent carbon-sulfur bond in the cystine molecule - a different bond, in a different place - and released cysteine that way. The findings were published in the journal Nature Chemical Biology, and reported on 23 September 2026.

Why this matters

At first glance this sounds like a detail only biochemists would care about. It is not. The immediate reason is cancer treatment. A number of promising cancer drug strategies work by starving tumour cells of something they need. Cysteine has been one of those targets, precisely because it was believed there was only one way in. If cells have a second route, that changes the picture. A drug that shuts the main door does not help much if there is a side door nobody knew about. It may explain why some tumours survive treatments that should, in theory, have killed them. The flip side is the opportunity. Now that the backup route has been identified, it becomes something researchers can aim at. Block both routes and the strategy might work as originally intended. There is a broader point too. Textbook biology is full of statements that begin "cells cannot". Every so often somebody tests one properly and finds the cell has an option nobody looked for. That is worth remembering the next time something is described as settled. Cells, it turns out, are more stubborn about staying alive than we gave them credit for.

What the evidence actually says

Careful reading matters here, because "could help fight cancer" is doing a lot of work in most coverage of this finding. What the researchers demonstrated is a biochemical mechanism. They showed that when cells are prevented from using the disulfide reductase route, an alternative chemical pathway releases cysteine by breaking a different bond in the cystine molecule. That is a genuine discovery about how cells work, published in a peer-reviewed journal. What has not happened is anything close to a treatment. There is no drug that blocks this pathway. There is no trial. There is no evidence in patients that shutting this route down makes any tumour easier to treat. The cancer link is a reasonable inference drawn by the researchers, not a tested result. The distance between "we found a mechanism" and "we have a medicine" is usually measured in a decade or more, and most mechanisms never make that journey. Many turn out to be harder to target than expected, or the drug that blocks them in a dish harms healthy cells too. That is not a criticism of the work. Basic science is supposed to find the mechanism first. It is just worth being clear about which stage we are at, because the gap between the two is where a lot of false hope gets generated.

Practical advice

If you or someone close to you is living with cancer, here is the useful version. Nothing about your treatment changes because of this study. Keep taking what has been prescribed, keep your appointments, and raise any questions with your oncology team rather than acting on news coverage. Do not take cysteine supplements, or N-acetylcysteine, in the hope of affecting cancer. The logic cuts the wrong way anyway - this research is about limiting cysteine supply to tumour cells, not increasing it. Supplements can also interact with treatments. Always check with your oncologist or pharmacist before adding anything, including things sold as natural. If you want to follow research in your own condition, Cancer Research UK's information pages explain what stage different approaches are at, in plain language, without overselling them. If you are interested in taking part in a trial, ask your consultant, or look at the NHS Be Part of Research service. Trials are how findings like this eventually reach patients, and they need volunteers. And if you see a website selling a product based on "blocking cancer's amino acid supply", close the tab. That product does not exist.

What to know

Researchers at Montana State University have discovered that mammalian cells can produce cysteine - an essential amino acid - through a backup pathway that was believed not to exist, by breaking a different chemical bond in cystine than the one science expected. The work was published in Nature Chemical Biology and reported on 23 September 2026. It matters because cysteine starvation has been explored as a way to kill cancer cells. A second route in may explain some treatment resistance, and it gives researchers a new target. But this is laboratory biochemistry, not a therapy. No drug exists, no trial has run, and no patient's care changes today. The practical advice is unchanged: follow your treatment plan, ask your oncology team before adding any supplement, and treat anything sold on the back of this finding as fiction. Sources: ScienceDaily, 'Scientists discover an "impossible" cellular survival pathway that could help fight cancer', 23 September 2026, https://www.sciencedaily.com/releases/2026/09/260923035939.htm; Nature Chemical Biology, 'A potent alternative cysteine production pathway allows reductase independence', 2026, https://www.nature.com/articles/s41589-026-02233-x; Montana State University research reported via bioengineer.org, 'Montana State Scientist Uncovers Key Cellular Mechanism with Potential to Advance Cancer Therapies', 2026, https://bioengineer.org/montana-state-scientist-uncovers-key-cellular-mechanism-with-potential-to-advance-cancer-therapies/ This article is for general information. It describes early laboratory research and does not replace advice from a doctor, pharmacist or other qualified healthcare professional.

#cancer research#cell biology#biochemistry#Nature Chemical Biology#amino acids#science

Related articles